Algernon Receives Positive Feedback from U.S. FDA for New Ifenprodil Intravenous Formulation
VANCOUVER, British Columbia, April 15, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or […]